Therefore, our findings support the hypothesis that anti-CD24 immunotherapy can inhibit the CD24/Siglec-10 signaling pathway and destroy the tumor cells through a variety of mechanisms, such as by blocking tumor cell “don’t eat me” signals, inducing apoptosis in tumor cells, triggering ADCP from macrophages and ADCC from NK cells. This evidence concerns the gene CD24 and neoplasm.